Slovenia to launch generic version of Viagra

Jul 31, 2009

Krka, the biggest drugmaker in Slovenia, said Friday that its generic version of the impotency drug Viagra would be launched in September and priced 30 percent cheaper than the original.

"We'll launch it first in Slovenia and later on, when the patents expire in other countries (in 2012), we'll offer it in central, eastern and western Europe as well," Krka chief executive Joze Colaric told the Internet news site, Zurnal24.

Russia, in particular, was seen as an important market.

Krka's version of the erectile dysfunction drug would be marketed under the name "vizarsin" and, unlike the blue pills made by US drug giant , would be white in colour, Colaric said.

The European Medicines Agency EMEA authorised the marketing of Krka's generic version of on June 25.

(c) 2009 AFP

Explore further: Teva to lift bid for Mylan: report

Related Stories

AIDS group objects to Viagra ads

Dec 14, 2006

An AIDS advocacy group in Los Angeles has asked the makers of Viagra to cease a marketing campaign that appears to promote the drug's recreational use.

European office withdraws Nexium patent

Dec 21, 2006

The European Patent Office, answering a generic drug maker's challenge, withdrew a patent on Britain-based AstraZeneca PLC's heartburn treatment, Nexium.

Viagra may aggravate sleep apnea

Sep 25, 2006

A study done in Brazil indicates a single dose of the erectile dysfunction drug Viagra may aggravate sleep apnea.

Cialis may have one-a-day version

Jun 13, 2006

U.S. drug giants Eli Lilly and Icos Corp. plan to seek regulatory approval to market a one-a-day version of their impotence-fighting drug Cialis.

Viagra sales don't meet expectations

May 20, 2007

While sales of erectile dysfunction drugs like Viagra have been steady since their release, their popularity has not met expectations, the Miami Herald said.

Recommended for you

Teva to lift bid for Mylan: report

14 hours ago

Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.

Vaccine for West Nile Virus enters human clinical trials

19 hours ago

A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.